May 31, 2018
Shigeru Mishima, President, Pharma Asset Research Takeda shareholders got the short end of the stick with the Shire deal, says ex-analyst Shigeru Mishima, criticizing the acquisition. Mr Mishima, now president of market research firm Pharma Asset Research, acts as a...read more